カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のコクシジウム症治療市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Coccidiosis Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23JU616）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23JU616
■ 発行日：2023年6月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆医療
■ ページ数：108
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥501,120見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥751,680見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,002,240見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のコクシジウム症治療市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界のコクシジウム症治療の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のコクシジウム症治療市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- コクシジウム症治療の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

コクシジウム症治療市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・イオノフォア医薬品、抗生物質医薬品、化学誘導体医薬品

用途別セグメント
・鶏肉、魚、牛

主要な市場プレーヤー
・Bayer Animal Health、Boehringer Ingelheim Vetmedica, Inc.、Ceva Sante Animale、Elanco (an Eli Lilly company)、Intas Pharmaceuticals Ltd.、Jurox Pty Ltd.、Merck Animal Health、Merial (a Sanofi company)、Vetoquinol S.A.、Virbac S.A.、Zoetis, Inc.、Novartis Animal Healthcare、Smartvet Inc.、Huvepharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、コクシジウム症治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なコクシジウム症治療メーカーの企業概要、2019年～2022年までのコクシジウム症治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なコクシジウム症治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別コクシジウム症治療の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのコクシジウム症治療のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのコクシジウム症治療市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびコクシジウム症治療の産業チェーンを掲載しています。
・第14、15章では、コクシジウム症治療の販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
- コクシジウム症治療の概要
- タイプ別分析（2018年vs2022年vs2029年）：イオノフォア医薬品、抗生物質医薬品、化学誘導体医薬品
- 用途別分析（2018年vs2022年vs2029年）：鶏肉、魚、牛
- 世界のコクシジウム症治療市場規模・予測
- 世界のコクシジウム症治療生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Bayer Animal Health、Boehringer Ingelheim Vetmedica, Inc.、Ceva Sante Animale、Elanco (an Eli Lilly company)、Intas Pharmaceuticals Ltd.、Jurox Pty Ltd.、Merck Animal Health、Merial (a Sanofi company)、Vetoquinol S.A.、Virbac S.A.、Zoetis, Inc.、Novartis Animal Healthcare、Smartvet Inc.、Huvepharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：イオノフォア医薬品、抗生物質医薬品、化学誘導体医薬品
・用途別分析2018年-2029年：鶏肉、魚、牛
・コクシジウム症治療の北米市場
- タイプ別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・コクシジウム症治療のヨーロッパ市場
- タイプ別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・コクシジウム症治療のアジア市場
- タイプ別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・コクシジウム症治療の南米市場
- タイプ別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・コクシジウム症治療の中東・アフリカ市場
- タイプ別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

According to our (Global Info Research) latest study, the global Coccidiosis Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Coccidiosis is a parasitic disease of a wide variety of animals caused by coccidian protozoa. The disease spreads from one animal to another by contact with infected feces or ingestion of infected tissue. Diarrhea is the primary symptom of Coccidiosis. Coccidia can infect a wide variety of animals, including humans, birds, and livestock, as they are usually species-specific. The coccidia are responsible for major economic losses of the livestock industry.
This report is a detailed and comprehensive analysis for global Coccidiosis Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Coccidiosis Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Coccidiosis Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Coccidiosis Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Coccidiosis Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Coccidiosis Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Coccidiosis Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer Animal Health, Boehringer Ingelheim Vetmedica, Inc., Ceva Sante Animale, Elanco (an Eli Lilly company) and Intas Pharmaceuticals Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Coccidiosis Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Ionophore Drugs
Antibiotic Drugs
Chemical Derivative Drugs
Market segment by Application
Poultry
Fish
Cattle
Major players covered
Bayer Animal Health
Boehringer Ingelheim Vetmedica, Inc.
Ceva Sante Animale
Elanco (an Eli Lilly company)
Intas Pharmaceuticals Ltd.
Jurox Pty Ltd.
Merck Animal Health
Merial (a Sanofi company)
Vetoquinol S.A.
Virbac S.A.
Zoetis, Inc.
Novartis Animal Healthcare
Smartvet Inc.
Huvepharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Coccidiosis Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Coccidiosis Treatment, with price, sales, revenue and global market share of Coccidiosis Treatment from 2018 to 2023.
Chapter 3, the Coccidiosis Treatment competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Coccidiosis Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Coccidiosis Treatment market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Coccidiosis Treatment.
Chapter 14 and 15, to describe Coccidiosis Treatment sales channel, distributors, customers, research findings and conclusion.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Coccidiosis Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Coccidiosis Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Ionophore Drugs
1.3.3 Antibiotic Drugs
1.3.4 Chemical Derivative Drugs
1.4 Market Analysis by Application
1.4.1 Overview: Global Coccidiosis Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Poultry
1.4.3 Fish
1.4.4 Cattle
1.5 Global Coccidiosis Treatment Market Size & Forecast
1.5.1 Global Coccidiosis Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Coccidiosis Treatment Sales Quantity (2018-2029)
1.5.3 Global Coccidiosis Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Bayer Animal Health
2.1.1 Bayer Animal Health Details
2.1.2 Bayer Animal Health Major Business
2.1.3 Bayer Animal Health Coccidiosis Treatment Product and Services
2.1.4 Bayer Animal Health Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bayer Animal Health Recent Developments/Updates
2.2 Boehringer Ingelheim Vetmedica, Inc.
2.2.1 Boehringer Ingelheim Vetmedica, Inc. Details
2.2.2 Boehringer Ingelheim Vetmedica, Inc. Major Business
2.2.3 Boehringer Ingelheim Vetmedica, Inc. Coccidiosis Treatment Product and Services
2.2.4 Boehringer Ingelheim Vetmedica, Inc. Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boehringer Ingelheim Vetmedica, Inc. Recent Developments/Updates
2.3 Ceva Sante Animale
2.3.1 Ceva Sante Animale Details
2.3.2 Ceva Sante Animale Major Business
2.3.3 Ceva Sante Animale Coccidiosis Treatment Product and Services
2.3.4 Ceva Sante Animale Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Ceva Sante Animale Recent Developments/Updates
2.4 Elanco (an Eli Lilly company)
2.4.1 Elanco (an Eli Lilly company) Details
2.4.2 Elanco (an Eli Lilly company) Major Business
2.4.3 Elanco (an Eli Lilly company) Coccidiosis Treatment Product and Services
2.4.4 Elanco (an Eli Lilly company) Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Elanco (an Eli Lilly company) Recent Developments/Updates
2.5 Intas Pharmaceuticals Ltd.
2.5.1 Intas Pharmaceuticals Ltd. Details
2.5.2 Intas Pharmaceuticals Ltd. Major Business
2.5.3 Intas Pharmaceuticals Ltd. Coccidiosis Treatment Product and Services
2.5.4 Intas Pharmaceuticals Ltd. Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Intas Pharmaceuticals Ltd. Recent Developments/Updates
2.6 Jurox Pty Ltd.
2.6.1 Jurox Pty Ltd. Details
2.6.2 Jurox Pty Ltd. Major Business
2.6.3 Jurox Pty Ltd. Coccidiosis Treatment Product and Services
2.6.4 Jurox Pty Ltd. Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Jurox Pty Ltd. Recent Developments/Updates
2.7 Merck Animal Health
2.7.1 Merck Animal Health Details
2.7.2 Merck Animal Health Major Business
2.7.3 Merck Animal Health Coccidiosis Treatment Product and Services
2.7.4 Merck Animal Health Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck Animal Health Recent Developments/Updates
2.8 Merial (a Sanofi company)
2.8.1 Merial (a Sanofi company) Details
2.8.2 Merial (a Sanofi company) Major Business
2.8.3 Merial (a Sanofi company) Coccidiosis Treatment Product and Services
2.8.4 Merial (a Sanofi company) Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Merial (a Sanofi company) Recent Developments/Updates
2.9 Vetoquinol S.A.
2.9.1 Vetoquinol S.A. Details
2.9.2 Vetoquinol S.A. Major Business
2.9.3 Vetoquinol S.A. Coccidiosis Treatment Product and Services
2.9.4 Vetoquinol S.A. Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Vetoquinol S.A. Recent Developments/Updates
2.10 Virbac S.A.
2.10.1 Virbac S.A. Details
2.10.2 Virbac S.A. Major Business
2.10.3 Virbac S.A. Coccidiosis Treatment Product and Services
2.10.4 Virbac S.A. Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Virbac S.A. Recent Developments/Updates
2.11 Zoetis, Inc.
2.11.1 Zoetis, Inc. Details
2.11.2 Zoetis, Inc. Major Business
2.11.3 Zoetis, Inc. Coccidiosis Treatment Product and Services
2.11.4 Zoetis, Inc. Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Zoetis, Inc. Recent Developments/Updates
2.12 Novartis Animal Healthcare
2.12.1 Novartis Animal Healthcare Details
2.12.2 Novartis Animal Healthcare Major Business
2.12.3 Novartis Animal Healthcare Coccidiosis Treatment Product and Services
2.12.4 Novartis Animal Healthcare Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Novartis Animal Healthcare Recent Developments/Updates
2.13 Smartvet Inc.
2.13.1 Smartvet Inc. Details
2.13.2 Smartvet Inc. Major Business
2.13.3 Smartvet Inc. Coccidiosis Treatment Product and Services
2.13.4 Smartvet Inc. Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Smartvet Inc. Recent Developments/Updates
2.14 Huvepharma
2.14.1 Huvepharma Details
2.14.2 Huvepharma Major Business
2.14.3 Huvepharma Coccidiosis Treatment Product and Services
2.14.4 Huvepharma Coccidiosis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Huvepharma Recent Developments/Updates
3 Competitive Environment: Coccidiosis Treatment by Manufacturer
3.1 Global Coccidiosis Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Coccidiosis Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Coccidiosis Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Coccidiosis Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Coccidiosis Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Coccidiosis Treatment Manufacturer Market Share in 2022
3.5 Coccidiosis Treatment Market: Overall Company Footprint Analysis
3.5.1 Coccidiosis Treatment Market: Region Footprint
3.5.2 Coccidiosis Treatment Market: Company Product Type Footprint
3.5.3 Coccidiosis Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Coccidiosis Treatment Market Size by Region
4.1.1 Global Coccidiosis Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Coccidiosis Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Coccidiosis Treatment Average Price by Region (2018-2029)
4.2 North America Coccidiosis Treatment Consumption Value (2018-2029)
4.3 Europe Coccidiosis Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Coccidiosis Treatment Consumption Value (2018-2029)
4.5 South America Coccidiosis Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Coccidiosis Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Coccidiosis Treatment Sales Quantity by Type (2018-2029)
5.2 Global Coccidiosis Treatment Consumption Value by Type (2018-2029)
5.3 Global Coccidiosis Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Coccidiosis Treatment Sales Quantity by Application (2018-2029)
6.2 Global Coccidiosis Treatment Consumption Value by Application (2018-2029)
6.3 Global Coccidiosis Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Coccidiosis Treatment Sales Quantity by Type (2018-2029)
7.2 North America Coccidiosis Treatment Sales Quantity by Application (2018-2029)
7.3 North America Coccidiosis Treatment Market Size by Country
7.3.1 North America Coccidiosis Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Coccidiosis Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Coccidiosis Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Coccidiosis Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Coccidiosis Treatment Market Size by Country
8.3.1 Europe Coccidiosis Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Coccidiosis Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Coccidiosis Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Coccidiosis Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Coccidiosis Treatment Market Size by Region
9.3.1 Asia-Pacific Coccidiosis Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Coccidiosis Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Coccidiosis Treatment Sales Quantity by Type (2018-2029)
10.2 South America Coccidiosis Treatment Sales Quantity by Application (2018-2029)
10.3 South America Coccidiosis Treatment Market Size by Country
10.3.1 South America Coccidiosis Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Coccidiosis Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Coccidiosis Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Coccidiosis Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Coccidiosis Treatment Market Size by Country
11.3.1 Middle East & Africa Coccidiosis Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Coccidiosis Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Coccidiosis Treatment Market Drivers
12.2 Coccidiosis Treatment Market Restraints
12.3 Coccidiosis Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Coccidiosis Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Coccidiosis Treatment
13.3 Coccidiosis Treatment Production Process
13.4 Coccidiosis Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Coccidiosis Treatment Typical Distributors
14.3 Coccidiosis Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Coccidiosis Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Coccidiosis Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bayer Animal Health Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Animal Health Major Business
Table 5. Bayer Animal Health Coccidiosis Treatment Product and Services
Table 6. Bayer Animal Health Coccidiosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bayer Animal Health Recent Developments/Updates
Table 8. Boehringer Ingelheim Vetmedica, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer Ingelheim Vetmedica, Inc. Major Business
Table 10. Boehringer Ingelheim Vetmedica, Inc. Coccidiosis Treatment Product and Services
Table 11. Boehringer Ingelheim Vetmedica, Inc. Coccidiosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boehringer Ingelheim Vetmedica, Inc. Recent Developments/Updates
Table 13. Ceva Sante Animale Basic Information, Manufacturing Base and Competitors
Table 14. Ceva Sante Animale Major Business
Table 15. Ceva Sante Animale Coccidiosis Treatment Product and Services
Table 16. Ceva Sante Animale Coccidiosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Ceva Sante Animale Recent Developments/Updates
Table 18. Elanco (an Eli Lilly company) Basic Information, Manufacturing Base and Competitors
Table 19. Elanco (an Eli Lilly company) Major Business
Table 20. Elanco (an Eli Lilly company) Coccidiosis Treatment Product and Services
Table 21. Elanco (an Eli Lilly company) Coccidiosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Elanco (an Eli Lilly company) Recent Developments/Updates
Table 23. Intas Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Intas Pharmaceuticals Ltd. Major Business
Table 25. Intas Pharmaceuticals Ltd. Coccidiosis Treatment Product and Services
Table 26. Intas Pharmaceuticals Ltd. Coccidiosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Intas Pharmaceuticals Ltd. Recent Developments/Updates
Table 28. Jurox Pty Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Jurox Pty Ltd. Major Business
Table 30. Jurox Pty Ltd. Coccidiosis Treatment Product and Services
Table 31. Jurox Pty Ltd. Coccidiosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Jurox Pty Ltd. Recent Developments/Updates
Table 33. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 34. Merck Animal Health Major Business
Table 35. Merck Animal Health Coccidiosis Treatment Product and Services
Table 36. Merck Animal Health Coccidiosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Merck Animal Health Recent Developments/Updates
Table 38. Merial (a Sanofi company) Basic Information, Manufacturing Base and Competitors
Table 39. Merial (a Sanofi company) Major Business
Table 40. Merial (a Sanofi company) Coccidiosis Treatment Product and Services
Table 41. Merial (a Sanofi company) Coccidiosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Merial (a Sanofi company) Recent Developments/Updates
Table 43. Vetoquinol S.A. Basic Information, Manufacturing Base and Competitors
Table 44. Vetoquinol S.A. Major Business
Table 45. Vetoquinol S.A. Coccidiosis Treatment Product and Services
Table 46. Vetoquinol S.A. Coccidiosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Vetoquinol S.A. Recent Developments/Updates
Table 48. Virbac S.A. Basic Information, Manufacturing Base and Competitors
Table 49. Virbac S.A. Major Business
Table 50. Virbac S.A. Coccidiosis Treatment Product and Services
Table 51. Virbac S.A. Coccidiosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Virbac S.A. Recent Developments/Updates
Table 53. Zoetis, Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Zoetis, Inc. Major Business
Table 55. Zoetis, Inc. Coccidiosis Treatment Product and Services
Table 56. Zoetis, Inc. Coccidiosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Zoetis, Inc. Recent Developments/Updates
Table 58. Novartis Animal Healthcare Basic Information, Manufacturing Base and Competitors
Table 59. Novartis Animal Healthcare Major Business
Table 60. Novartis Animal Healthcare Coccidiosis Treatment Product and Services
Table 61. Novartis Animal Healthcare Coccidiosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Novartis Animal Healthcare Recent Developments/Updates
Table 63. Smartvet Inc. Basic Information, Manufacturing Base and Competitors
Table 64. Smartvet Inc. Major Business
Table 65. Smartvet Inc. Coccidiosis Treatment Product and Services
Table 66. Smartvet Inc. Coccidiosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Smartvet Inc. Recent Developments/Updates
Table 68. Huvepharma Basic Information, Manufacturing Base and Competitors
Table 69. Huvepharma Major Business
Table 70. Huvepharma Coccidiosis Treatment Product and Services
Table 71. Huvepharma Coccidiosis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Huvepharma Recent Developments/Updates
Table 73. Global Coccidiosis Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Coccidiosis Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Coccidiosis Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Coccidiosis Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Coccidiosis Treatment Production Site of Key Manufacturer
Table 78. Coccidiosis Treatment Market: Company Product Type Footprint
Table 79. Coccidiosis Treatment Market: Company Product Application Footprint
Table 80. Coccidiosis Treatment New Market Entrants and Barriers to Market Entry
Table 81. Coccidiosis Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Coccidiosis Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Coccidiosis Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Coccidiosis Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Coccidiosis Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Coccidiosis Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Coccidiosis Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Coccidiosis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Coccidiosis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Coccidiosis Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Coccidiosis Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Coccidiosis Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Coccidiosis Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Coccidiosis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Coccidiosis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Coccidiosis Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Coccidiosis Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Coccidiosis Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Coccidiosis Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Coccidiosis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Coccidiosis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Coccidiosis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Coccidiosis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Coccidiosis Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Coccidiosis Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Coccidiosis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Coccidiosis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Coccidiosis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Coccidiosis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Coccidiosis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Coccidiosis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Coccidiosis Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Coccidiosis Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Coccidiosis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Coccidiosis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Coccidiosis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Coccidiosis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Coccidiosis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Coccidiosis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Coccidiosis Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Coccidiosis Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Coccidiosis Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Coccidiosis Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Coccidiosis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Coccidiosis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Coccidiosis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Coccidiosis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Coccidiosis Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Coccidiosis Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Coccidiosis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Coccidiosis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Coccidiosis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Coccidiosis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Coccidiosis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Coccidiosis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Coccidiosis Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Coccidiosis Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Coccidiosis Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Coccidiosis Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Coccidiosis Treatment Raw Material
Table 141. Key Manufacturers of Coccidiosis Treatment Raw Materials
Table 142. Coccidiosis Treatment Typical Distributors
Table 143. Coccidiosis Treatment Typical Customers
List of Figures
Figure 1. Coccidiosis Treatment Picture
Figure 2. Global Coccidiosis Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Coccidiosis Treatment Consumption Value Market Share by Type in 2022
Figure 4. Ionophore Drugs Examples
Figure 5. Antibiotic Drugs Examples
Figure 6. Chemical Derivative Drugs Examples
Figure 7. Global Coccidiosis Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Coccidiosis Treatment Consumption Value Market Share by Application in 2022
Figure 9. Poultry Examples
Figure 10. Fish Examples
Figure 11. Cattle Examples
Figure 12. Global Coccidiosis Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Coccidiosis Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Coccidiosis Treatment Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Coccidiosis Treatment Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Coccidiosis Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Coccidiosis Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Coccidiosis Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Coccidiosis Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Coccidiosis Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Coccidiosis Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Coccidiosis Treatment Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Coccidiosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Coccidiosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Coccidiosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Coccidiosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Coccidiosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Coccidiosis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Coccidiosis Treatment Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Coccidiosis Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Coccidiosis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Coccidiosis Treatment Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Coccidiosis Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Coccidiosis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Coccidiosis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Coccidiosis Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Coccidiosis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Coccidiosis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Coccidiosis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Coccidiosis Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Coccidiosis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Coccidiosis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Coccidiosis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Coccidiosis Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Coccidiosis Treatment Consumption Value Market Share by Region (2018-2029)
Figure 54. China Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Coccidiosis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Coccidiosis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Coccidiosis Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Coccidiosis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Coccidiosis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Coccidiosis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Coccidiosis Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Coccidiosis Treatment Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Coccidiosis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Coccidiosis Treatment Market Drivers
Figure 75. Coccidiosis Treatment Market Restraints
Figure 76. Coccidiosis Treatment Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Coccidiosis Treatment in 2022
Figure 79. Manufacturing Process Analysis of Coccidiosis Treatment
Figure 80. Coccidiosis Treatment Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source

※参考情報

コクシジウム症は、原虫の一種であるコクシジウム属によって引き起こされる感染症であり、特に家畜やペットを含む多くの動物に影響を及ぼします。この病気は、主に腸および腸管に感染し、腸粘膜に損傷を与えることによって下痢や脱水などの症状を引き起こします。コクシジウム症は特に幼齢動物や免疫抑制状態にある動物において重篤な影響を及ぼすことがあります。

コクシジウムの感染は、主に糞便を介して伝播されます。感染した動物の糞便中に放出されるオシスト（卵のような構造）が、環境中で発育し、そのオシストを摂取することにより新たな感染が成立します。そのため、特に衛生管理の行き届いていない状況では、コクシジウム症が広がりやすいです。コクシジウム症は、ウシ、ブタ、鶏、ウサギや犬、猫など多くの動物種に見られますが、各種によって病原性を持つ種類や症状が異なるため、注意が必要です。

コクシジウム症の症状は、感染の重症度や動物種によって異なりますが、一般的には激しい下痢、食欲不振、体重減少、脱水、元気消失などが見受けられます。特に若齢の動物においては、生命に危険を及ぼすような重症化する可能性もあります。ウシや豚などの反芻動物では、下痢の一環として血液や粘液を含む便が観察されることがあります。

コクシジウム症の治療には、主に抗コクシジウム剤と呼ばれる薬物が使用されます。一般的な抗コクシジウム剤には、モネンシン、サルファメトキシン、トリメトプリム・サルファメトキシン、イオノフォア類などがあります。これらの薬物は、特に細胞内でのコクシジウムの増殖を抑える働きがあり、下痢やその他の症状を軽減するのに役立ちます。

また、治療においては、抗コクシジウム剤の投与と並行してサポーティブケアが非常に重要です。脱水状態にある動物には、電解質を含む水分補給が必要です。そして、栄養補給も重要であり、消化が良く、栄養価の高い餌を与えることが推奨されます。重症例では、インフュージョン治療や栄養補給が必要となることもあります。

治療法に加え、予防策も非常に重要です。特に家畜やペットの飼育環境では、衛生管理を徹底し、感染源である糞便の処理を適切に行うことが必要です。また、新たな動物を導入する際には、健康状態の確認や隔離期間を設けることで、感染拡大を防ぐことが求められます。

コクシジウム症の予防には、飼料添加物としての抗コクシジウム剤の使用も一般的です。特に鶏や豚の飼育においては、成長促進や感染防止の目的で抗コクシジウム剤を飼料に添加することが行われています。このような飼料添加物は、特に生産性を重視する養殖場や畜産業において、その効果が注目されています。

近年では、コクシジウム症に対するワクチン開発の研究も進められています。ワクチンによる免疫獲得が可能となれば、保護効果を持つことで感染リスクを大幅に減少できると期待されています。ただし、ワクチン開発には時間がかかるため、現時点では他の治療法や予防策と併せて検討する必要があります。

このように、コクシジウム症の治療は多岐にわたりますが、最も重要なのは早期発見と適切な治療、さらには感染予防対策です。特に飼育環境が感染リスクの増加に大きく寄与するため、飼い主は衛生管理を徹底し、定期的に動物の健康状態をチェックすることが求められます。最近の研究では、コクシジウムに対する新たな治療法や予防策が模索されており、引き続き情報を収集し、学び続けることが重要です。動物の健康を守るためには、飼い主自身が知識を深め、必要な行動を取ることが大切であると言えます。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の動物精子細胞凍結保存培地市場2023年：企業・地域・タイプ・用途別分析
  • 世界の動物呼吸麻酔器市場2023年：企業・地域・タイプ・用途別分析
  • 世界の鼓膜治療装置市場2023年：企業・地域・タイプ・用途別分析
  • 世界の汎ぶどう膜炎治療市場2023年：企業・地域・タイプ・用途別分析
  • 世界の弱視治療装置市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23JU616 )"世界のコクシジウム症治療市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Coccidiosis Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。